Results 1 to 10 of about 9,103 (265)

Role of Phospholipases A2 in Vascular Relaxation and Sympatholytic Effects of Five Australian Brown Snake, Pseudonaja spp., Venoms in Rat Isolated Tissues [PDF]

open access: goldFrontiers in Pharmacology, 2021
Human envenoming by Australian brown snakes (Pseudonaja spp.) may result in potentially life-threatening hypotension and subsequent cardiovascular collapse.
Nhi Thuc Vuong   +2 more
doaj   +3 more sources

Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland [PDF]

open access: goldInternational Journal of Molecular Sciences, 2021
Heart failure (HF) remains the leading cause of morbidity and death in the western world, and new therapeutic modalities are urgently needed to improve the lifespan and quality of life of HF patients.
Anastasios Lymperopoulos
exaly   +3 more sources

Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition [PDF]

open access: hybridCurrent Hypertension Reports, 2022
Purpose of Review The moderate glucose-lowering effect of sodium glucose co-transporter 2 (SGLT2) inhibitors is unlikely to explain SGLT2 inhibitor-mediated beneficial outcomes, and unravelling the underlying mechanisms is a high priority in the research
Lakshini Herat   +2 more
exaly   +3 more sources

Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes [PDF]

open access: bronzeDiabetes Care, 2011
Bromocriptine is a sympatholytic D2-dopamine agonist that has been approved for the treatment of type 2 diabetes. Based on animal and human studies, timed bromocriptine administration within 2 h of awakening is believed to augment low hypothalamic ...
R. DeFronzo
exaly   +3 more sources

Direct Vasodilators and Sympatholytic Agents [PDF]

open access: bronzeJournal of Cardiovascular Pharmacology and Therapeutics, 2015
Direct vasodilators and sympatholytic agents were some of the first antihypertensive medications discovered and utilized in the past century. However, side effect profiles and the advent of newer antihypertensive drug classes have reduced the use of these agents in recent decades.
Meghan N, McComb   +2 more
semanticscholar   +4 more sources

Central Sympatholytic Drugs [PDF]

open access: bronzeJournal of Clinical Hypertension, 2011
Wanpen Vongpatanasin
exaly   +4 more sources

Endovascular renal denervation: a novel sympatholytic with relevance to chronic kidney disease [PDF]

open access: bronzeClinical Kidney Journal, 2013
Endovascular renal denervation (sympathectomy) is a novel procedure developed for the treatment of resistant hypertension. Evidence suggests that it reduces both afferent and efferent sympathetic nerve activity, which may offer clinical benefit over and ...
N. Hoye   +5 more
semanticscholar   +2 more sources

ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY

open access: greenРациональная фармакотерапия в кардиологии, 2015
Aim. To evaluate the effect of imidasoline agonist, rilmenidine (Albarel), on 24-hour blood pressure (BP) profile and autonomic regulation of cardiovascular system in young patients with arterial hypertension (HT) and exogenous constitutional obesity ...
N. N. Nikitina   +3 more
doaj   +6 more sources

Home - About - Disclaimer - Privacy